Colon Targeting Guar Gum Microspheres of 5-Aminosalicylic Acid: Evaluation of Various Process Variables, Characterization and In-vitro Drug Release
Dinesh Kaushik1, Kavita Sharma1, Satish Sardana1
- 1Department of Pharmaceutics, Hindu College of Pharmacy, Sonepat (Haryana) INDIA.
CORRESPONDENCE
Received: 04-07-2015; Revised: 18-08-2015; Accepted: 13-02-2016.
Volume 50, Issue 2S · pp. s106–s114 · PUBLISHED 2026 · DOI: 10.5530/ijper.50.2.25
ABSTRACT
Background and objectives: 5-Amino salicylic acid (5-ASA), a drug of choice for the treatment of crohn’s disease and ulcerative colitis, rapidly absorbs from the small intestine and there is little localization of 5-ASA in the colon. Thus, we have developed a colon-specific delivery cargo of 5-ASA to release the maximum drug in colon. Methods and Results: 5-ASA loaded guar gum microspheres were prepared by emulsion polymerization technique and optimized for particle size, entrapment efficiency and in-vitro drug release in colonic environment. FTIR, PXRD and DSC were used as the techniques to characterize the drug-polymer interaction. 5-ASA-loaded microspheres offer high entrapment efficiency of 82.39 ± 1.06% with a mean particle size of 150.32 ± 11.8 μm. In-vitro release of optimized formulation indicated 9.32 ± 0.63 % release of drug in SGF (pH 1.2; without pepsin); 13.93 ± 0.90 % in SIF (pH 7.5), 32.11 ± 2.80 % in SCF (pH 7.0; without rat caecal contents) while a significant increase in drug release (94.62 ± 4.50%) was observed in SCF (pH 7.0) medium containing 4% rat caecal content after 6 days of enzyme induction. Conclusion: 5-ASA loaded guar gum microspheres can be used as therapeutic agent for the treatment of ulcerative colitis.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Kaushik, D., Sharma, K., & Sardana, S. (2026). Colon Targeting Guar Gum Microspheres of 5-Aminosalicylic Acid: Evaluation of Various Process Variables, Characterization and In-vitro Drug Release. Indian Journal of Pharmaceutical Education and Research, 50(2S), s106–s114. https://doi.org/10.5530/ijper.50.2.25
